Crossref
Analysis of mechanisms increasing the risk of inhibitor development during hemophilia A treatment
Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 425-433
DOI: 10.5603/ahp.111944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Anna Lubkowska und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lubkowska, A., Paczkowska, A., Kempińska-Podhorodecka, A. D., & Urasiński, T. (2026). Analysis of mechanisms increasing the risk of inhibitor development during hemophilia A treatment. Acta Haematologica Polonica, 57(5), 425-433. https://doi.org/10.5603/ahp.111944
Vancouver
Lubkowska A, Paczkowska A, Kempińska-Podhorodecka AD, Urasiński T. Analysis of mechanisms increasing the risk of inhibitor development during hemophilia A treatment. Acta Haematologica Polonica. 2026;57(5):425-433. doi:10.5603/ahp.111944
BibTeX
@article{Lubkowska2026,
author = {Lubkowska, Anna and Paczkowska, Anna and Kempińska-Podhorodecka, Agnieszka Daniela and Urasiński, Tomasz},
title = {Analysis of mechanisms increasing the risk of inhibitor development during hemophilia A treatment},
journal = {Acta Haematologica Polonica},
year = {2026},
volume = {57},
number = {5},
pages = {425--433},
doi = {10.5603/ahp.111944}
}
EUVIMED